title: The intracellular functions of alpha6beta4 integrin are regulated by EGF.
abstract: Upon ligand binding, the alpha6beta4 integrin becomes phosphorylated on tyrosine residues and combines sequentially with the adaptor molecules Shc and Grb2, linking to the ras pathway, and with cytoskeletal elements of hemidesmosomes. Since alpha6beta4 is expressed in a variety of tissues regulated by the EGF receptor (EGFR), we have examined the effect of EGF on the cytoskeletal and signaling functions of alpha6beta4. Experiments of immunoblotting with anti-phosphotyrosine antibodies and immunoprecipitation followed by phosphoamino acid analysis and phosphopeptide mapping showed that activation of the EGFR causes phosphorylation of the beta4 subunit at multiple tyrosine residues, and this event requires ligation of the integrin by laminins or specific antibodies. Immunoprecipitation experiments indicated that stimulation with EGF does not result in association of alpha6beta4 with Shc. In contrast, EGF can partially suppress the recruitment of Shc to ligated alpha6beta4. Immunofluorescent analysis revealed that EGF treatment does not induce increased assembly of hemidesmosomes, but instead causes a deterioration of these adhesive structures. Finally, Boyden chamber assays indicated that exposure to EGF results in upregulation of alpha6beta4-mediated cell migration toward laminins. We conclude that EGF-dependent signals suppress the association of activated alpha6beta4 with both signaling and cytoskeletal molecules, but upregulate alpha6beta4-dependent cell migration. The changes in alpha6beta4 function induced by EGF may play a role during wound healing and tumorigenesis.
authors.affiliation: Department of Pathology, Kaplan Cancer Center, New York University School of Medicine, New York 10016, USA.
authors.forename: F
authors.initials: F
authors.lastname: Mainiero
authors.forename: A
authors.initials: A
authors.lastname: Pepe
authors.forename: M
authors.initials: M
authors.lastname: Yeon
authors.forename: Y
authors.initials: Y
authors.lastname: Ren
authors.forename: F G
authors.initials: FG
authors.lastname: Giancotti
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D033942:Adaptor Proteins, Vesicular Transport; D015703:Antigens, CD / Q000502:physiology*; D002448:Cell Adhesion; D002465:Cell Movement; D016764:Cell Polarity; D002478:Cells, Cultured; D003896:Desmosomes / Q000648:ultrastructure; D004815:Epidermal Growth Factor / Q000502:physiology*; D066246:ErbB Receptors / Q000502:physiology*; D051380:GRB2 Adaptor Protein; D006801:Humans; D039503:Integrin alpha6; D039663:Integrin beta4; D008024:Ligands; D010766:Phosphorylation; D019000:Phosphotyrosine / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D017474:Receptors, Laminin / Q000502:physiology; D055765:Shc Signaling Adaptor Proteins; D015398:Signal Transduction; D000071425:Src Homology 2 Domain-Containing, Transforming Protein 1
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D033942:Adaptor Proteins, Vesicular Transport; D015703:Antigens, CD; D051380:GRB2 Adaptor Protein; C495948:GRB2 protein, human; D039503:Integrin alpha6; D039663:Integrin beta4; D008024:Ligands; D011506:Proteins; D017474:Receptors, Laminin; C528024:SHC1 protein, human; D055765:Shc Signaling Adaptor Proteins; D000071425:Src Homology 2 Domain-Containing, Transforming Protein 1; D019000:Phosphotyrosine; D004815:Epidermal Growth Factor; D066246:ErbB Receptors